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ABSTRACT
Objective: The study’s purpose has been to assess the validation of irregular antibodies investigation using 
the Coombs control reagent in blood samples collected over the period from February 2015 to August 2016. 
Methods: It is a observational, retrospective and prospective study, which presents technical procedures bearing 
a documentary character, and that was performed at the Laboratory of Immunohematology from the Regional 
Blood Center in Montes Claros-MG. Results: During the research, it was observed that after the non-validation 
of some tests and its repetition was then performed alone; the validation was not verified and once again a 
repetition was necessary until this sample was defined as validated. This fact raises the possibility of other 
interferences beyond those both known and discussed; bearing in mind that the repetition was carried out in 
isolation and also all stages of the process were performed under scrutiny. Conclusion: The low percentage of 
non-validated results ratifies that the antiglobulin validation test is a good method to confirm the result of the 
search for irregular antibodies.
Descriptors: Antibodies, Validation, Blood Donors, Coombs’ Test. 
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RESUMO
Objetivo: Analisar a validação da pesquisa de anticorpos irregulares 
(PAI) através da utilização do reagente Controle de Coombs em amostras 
sanguíneas coletadas de Fevereiro de 2015 à Agosto de 2016. Métodos: 
Estudo de natureza observacional, retrospectiva e prospectiva, apresentando 
procedimentos técnicos de caráter documental, a ser realizado no Laboratório 
de Imunohematologia do Hemocentro Regional de Montes Claros - MG. 
Resultados: Foi observado durante a pesquisa que após a não validação 
de alguns testes e realizada a repetição dos mesmos isoladamente, não foi 
constatado a validação sendo necessário outra repetição até que essa amostra 
validasse. Esse fato levanta a possibilidade de outras interferências além das 
conhecidas e discutidas, uma vez que a repetição foi realizada isoladamente 
analisando criticamente todas as etapas do processo. Conclusão: O baixo 
percentual de resultados não validados ratifica que o teste de validação 
antiglobulínico é um bom método para confirmar o resultado da pesquisa 
de anticorpos irregulares. 
Descritores: Anticorpos, Validação, Doadores de Sangue, Teste de Coombs.
RESUMEN
Objetivo: Analizar lavalidación de la detección de anticuerpos irregulares 
(PAI) mediante el uso del reactivo de control de Coombs en muestras de 
sangre tomadas de Febrero 2015 a Agosto 2016.  Métodos: Estudio de 
naturaleza observacional, retrospectivo y prospectivo, con los procedimientos 
técnicos de carácter documental, que se sucederá em Laboratorio de 
Inmunohematología del Hemocentro Regional de Montes Claros - MG. 
Resultados: Se observó durante la encuesta que después de la no validación 
de algunos testes y sucedida la repetición del mismos individuos, no se ha 
encontrado la validación, por lo tanto requeiendo otra repetición hasta que 
la validación de la muestra. Esto plantea la posibilidad de interferencia que 
no sea el conocido y discutido, ya que la repetición se realiza aisladamente el 
análisis crítico de todos los pasos del proceso. Conclusión: El bajo porcentaje 
de resultados no validados ratifica la prueba de validación antiglobulínico es 
un buen método para confirmar el resultado de la búsqueda de anticuerpos 
irregulares. 
Descriptores: Anticuerpos, Validación, Los Donantes de Sangre, Prueba 
de Coombs.
INTRODUCTION
The identification of erythrocyte antigens and the 
definition of their importance in transfusion practice and 
hemolytic disease of the newborn occurred in the first half 
of the twentieth century, characterizing advances in medical 
research.1 According to the International Society of Blood 
Transfusion, there are about 340 antigens, 308 of which are 
grouped into 36 blood-group systems, and much progress 
is still being made in the understanding and structural and 
functional analysis of antigens expressed in Red Blood Cells 
(RBCs) and in non-erythroid tissues.1
There are several types of irregular antibodies in different 
forms. After the discovery of blood groups, A, B, O in 1900 
by Karl Landsteiner, several antigens and antibodies were 
found in the erythrocyte membranes. These antibodies were 
classified as significant when they agglutinated the RBCs, 
reducing their survival; and insignificant when agglutinated, 
since it did not affect survival in the organism.2
These antibodies were named as Rh, KELL, MNSs, Lewis, 
Duffy and Kidd; they are identified in either serum or plasma 
from donors and in patients undergoing blood transfusions. 
This is because each of these antigens has biological functions 
that are capable of causing reactions to erythrocytes and 
when in contact with the human antigen causes immediate, 
late reactions or sudden death of the patient.3 The Rh, MNS 
and KELL systems are the most complex, and have 54, 48 
and 35 antigens, respectively.4
When the individual is exposed to substances foreign 
to the body, such as erythrocyte antigens, activation of the 
immune system with a formation of irregular antibodies 
can occur, resulting in a response, antigens contained in 
transfused blood components. Irregular antibodies occur 
in approximately 0.3 to 2.0% of the general population, can 
be found in the serum/plasma of individuals or linked to 
the erythrocyte membrane. After the presence of irregular 
antibodies has been identified, the specificity of these 
antibodies using a panel of RBCs with known phenotypes 
in immunogenic systems.5-6
The Search for Irregular Antibodies (SIA) should be 
performed in the blood of donors using methods capable 
of detecting the presence of clinically relevant antibodies as 
determined by the Resolution No. 34 of June 11th, 2014, and 
Ordinance No. 158 of 04 of February 2016, which approve 
the technical regulation of hemotherapy procedures.7-8
Irregular antibodies occur in up to 3% of transfused 
patients; but in some patients, this risk is more significant 
about 7 to 10% in poly transfused patients, 6 to 36% in sickle 
individuals and 3 to 10% in thalassemia.9 Some authors 
have reported up to more than 30% alloimmunization in 
these patients.9
The frequency of irregular antibodies in a poly transfused 
population shows the prevalence in onco-hematologic 
patients, aplastic anemia, acute myelogenous leukemia of 
11-16%, with chronic diseases such as chronic renal failure 
and upper gastrointestinal bleeding, with results of 11-16%, 
patients with hemoglobinopathies, such as sickle cell anemia 
and alloimmunization expressed a percentage of 33.4%.10-11
The occurrence of negative results when antibody 
concentration is below detectable limits represents limitation 
to the antibody detection test. Usually, this occurs in elderly 
people or in those not exposed to the corresponding antigen.12
The present study aimed to analyze the validation of SIA 
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through the use of Coombs Control reagent in blood samples 
from donors who attended the Regional Blood Center of 
Montes Claros city over the period from February 2015 to 
August 2016. Moreover, study also aims to investigate possible 
causes for the non-validation of the tests, and to discuss ways 
of minimizing divergences in the results.
METHODS
It is a observational, retrospective and prospective 
study, which presents technical procedures bearing a 
documentary character, and that was performed at the 
Laboratory of Immunohematology from the Regional Blood 
Center in Montes Claros-MG. To collect data, it was used 
information about the results of the validation of the irregular 
antibody test of blood donors, cataloged in the worksheets 
“Immunohematology Service” and “Validation of the search 
for irregular antibodies” over the period from 2015 to 2016. 
A descriptive analysis was performed using a Microsoft Office 
Excel spreadsheet (version 2010). The research was carried out 
according to the Resolution No. 466/2012 from the National 
Health Council, after consent of the person responsible 
for the Blood Center and approval of the Research Ethics 
Committee from the Faculdades Integradas do Norte de Minas 
(FUNORTE), under number No. 57468116.0.0000.5141.
RESULTS AND DISCUSSION
The Regional Blood Center in Montes Claros-MG is 
responsible for all the demand for transfusion procedures, 
public and private, of the macro-region of Northern region 
of the Minas Gerais State. It attends on average about 2000 
candidates for a donation per month, where about 1,500 
blood bags/month are collected. According to the Ordinance 
No. 158 of February 4th, 2016, and the Resolution No. 34 of 
June 11th, 2014, the search for irregular antibodies must be 
performed in the blood of donors at each donation using 
methods capable of detecting the presence of clinically 
relevant antibodies. This technique is developed in the 
Laboratory of Immunohematology that participates in 
the external quality control of the Brazilian Association 
of Hematology and Hemotherapy with managed and 
satisfactory results, in addition to having a daily internal 
quality control protocol.
The SIA of the blood donors is made according to 
standard operating procedure, in calibrated and validated 
centrifuges for washing and reading the results, being 
performed by tube methodology using polyethylene glycol as 
a potentiating agent. Agglutination readings are performed 
by the addition of Human Antiglobulin (HAG) serum and, 
after a negative result; they are validated using the Coombs 
control reagent. If any sample is not validated, repeat the test.
Data were collected from February 2015 to August 
2016 over a period of 19 months between the two years. 
During this period, 24,136 tests for irregular antibodies 
were performed, where 853 tests did not validate after the 
addition of the Coombs Control RBCs, which corresponded 
to 3.53% of the tests performed, observed in Figure 1. 
Figure 1 – : The research quantitative and the results validation for 
irregular antibodies investigation. Regional Blood Center in Montes Claros-
-MG, Brazil, February/2015 to August/2016.
Data regarding the agglutination intensity of the validated 
tests were also collected. 535 tests agglutinated with traces, 
which corresponds to 2.2% of tests performed; 1,853 tests 
agglutinated with intensity of 1+, equivalent to 7.7% of the 
total of tests performed in the period evaluated; 18,812 tests 
agglutinated with intensity of 2+, corresponding to 77.9% of 
the total of tests; 2,897 tests agglutinated with 3+, which is 
equivalent to 12% of the tests; and 39 tests agglutinated with 
4+ corresponding to 0.2% of the tests, as shown in Figure 2. 
Figure 2 – : The research quantitative and the results validation for 
irregular antibodies investigation. Regional Blood Center in Montes Cla-
ros-MG, Brazil, February/2015 to August/2016.
The agglutination intensity results in which most of the 
tests agglutinated with 2+ or 3+ are in accordance with the 
thecnical leaflet from the reagent used, which establishes 
those levels as the specified grade.
In view of the 853 tests not validated after the addition 
of Coombs Control RBCs, corresponding to 3.53% of the 
tests performed, may be justified by several factors that may 
influence the non-validation of the indirect Coombs’ test, 
and those factors added to an extensive routine might lead 
to false results during the irregular antibodies investigation.
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Each step of the test should be performed carefully to 
ensure reliable results. Incubation of the RBCs with antisera 
allows the antibody molecules to bind to the antigen present 
on the RBCs membrane, and it is important to monitor the 
optimal incubation temperature of the test that is optimal 
at 37°C for most of the IgG antibodies.12
Another factor that may also contribute to non-validation 
of the tests is saline lavage to remove all residual free globulins 
that can neutralize the HAG reagent.12
Given the aforementioned, by facing a very extensive 
routine, the technician may not realize that the three required 
washes were carried out and proceed to the next step without 
completing the proper washing of the RBCs. It is critical to 
discard the entire supernatant after the final wash and proceed 
with the drying of the tubes, as the remainder of saline dilutes 
the HAG reagent and decreases the sensitivity of the test.
During the research, it was observed that after the non-
-validation of some tests and its repetition was then perfor-
med alone; the validation was not verified and once again 
a repetition was necessary until this sample was defined as 
validated. This fact raises the possibility of other interferences 
beyond those known and discussed, bearing in mind that 
the repetition was carried out in isolation and also all stages 
of the process were performed under scrutiny. 
CONCLUSIONS
The low percentage of non-validated results endorses 
that the antiglobulin validation test is a good method to 
confirm the result of the irregular antibodies investigation. 
Furthermore, the negative result, when present, may occur 
due to process-related interferences that influence the 
technique.
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